Compositions and methods for enhancing the immunogenicity of antigens
US7662396B2 · kind B2 · utility
24Cited by
14References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2006 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Jul 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides recombinant polypeptides comprising an N-terminal fragment of an ActA protein or LLO protein fused to an antigen or a fragment thereof, nucleotides encoding same, recombinant vectors comprising same, and immunogenic and therapeutic methods utilizing same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.